3
Aug 27 (Reuters) – AstraZeneca PLC: * ASTRAZENECA PLC – TEZSPIRE CROSSING TRIAL MET PRIMARY ENDPOINTS * ASTRAZENECA PLC – TEZSPIRE CROSSING TRIAL MET PRIMARY ENDPOINTS * ASTRAZENECA – TEZSPIRE
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
